| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.28 | 3e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.24 | 3e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.23 | 6e-10 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.21 | 6e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 7e-08 |